drugset / Trial / NCT02654041
Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
NaSingle-groupOpen-labelSupportive care
Summary
The objective of the study is to assess the safety and efficacy of treatment with hypothyroxinemia adjunct to conventional therapies in GBM patients.
Timeline
- Start
- 2016-03
- Primary completion
- 2017-06
- Completion
- 2017-06
Outcome
Outcome not reported
Stopped: “Drug manufacturer no longer could supply for study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methimazole | Small molecule | — | Oral |
| Subject | T3 | Unknown | — | Oral |